January 6, 2020
National Eye Institute (NEI)
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
National Institute on Drug Abuse (NIDA)
National Institute of Environmental Health Sciences (NIEHS)
The NIH is inviting administrative supplement applications to provide additional funds to active CounterACT research grants or cooperative agreement projects to support activities such as new collaborations and pilot studies that were unanticipated at the time that the new or competing continuation application was submitted. All proposed activities must be within the original research scope of the parent award. Supplemental funding includes all direct costs as well as associated facilities and administrative costs. The supplement project can start at any time during the budget period but must end on the last day of the budget period. The parent award may not be in terminal no-cost extension or going into a no-cost extension in FY2020.
Application budgets are limited to $75,000 total costs and must reflect the actual needs of the proposed project.
Only parent CounterACT research grant and cooperative agreement awards funded through the following FOAs (and any reissues of these announcements) are eligible to request supplemental funding under this NOSI:
Scope of Interest
The overall goal of the NIH Countermeasures Against Chemical Threats (CounterACT) program is to support research and development of therapeutics that can reduce mortality and morbidity in the event of the release of chemical threat agents. Chemical threat agents are toxic compounds that could be released by a deliberate terrorist attack against civilians, or by accidental or natural disaster causing mass casualties. These include chemical warfare agents (e.g., sarin, chlorine, sulfur mustard), toxic industrial chemicals (e.g., cyanide, hydrogen sulfide, phosgene), pesticides (e.g., parathion, brodifacoum), pharmaceutical-based agents (e.g., opioids) and other chemicals. Applications proposing research on chemical threats that are not of interest to the program will not be considered for funding. If research related to opioid threats is being proposed, see NOT-NS-18-019 for a description of research supported by the NIH CounterACT program.
Examples of topics of interest include, but are not limited to:
Investigators planning to submit an application in response to this NOSI are strongly advised to contact and discuss their proposed research/aims with the Program Officer of their parent CounterACT award well in advance of the receipt deadline to better determine appropriateness and relevance of the supplement project
Application and Submission Information
Applications for this initiative must be submitted using the following opportunity or its subsequent reissued equivalent.
Research Strategy As part of the application, summarize the scope of the parent and supplemental projects and describe the proposed aims and research strategy for the new study. Clearly state how the supplemental efforts fit into the scope of the parent award. The research strategy should clearly demonstrate how the new collaboration(s), resource(s), and/or studies will benefit the parent award and why those would otherwise not be feasible either within the currently funded efforts or by rebudgeting funds.
Applicants to the program are urged to consider and directly address elements of rigor and reproducibility as described in NOT-OD-15-103 in their experimental design.
Administrative Evaluation Criteria
Letters of Support
Applicants must include a letter from appropriate institutional biosafety officials indicating that studies are deemed safe for research personnel and the environment. A formal letter of support must be provided for all newly proposed collaborative, consultative, and/or contract arrangements.
Please direct all inquiries related to the overall NIH CounterACT Program and/or parent awards managed by the National Institutes of Neurological Disorders and Stroke (NINDS) to:
David A. Jett, PhD
Shardell M. Spriggs, PhD
For parent awards managed by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS):
Hung Tseng, Ph.D.
For parent awards managed by the National Eye Institute (NEI):
Houmam Araj, Ph.D.
For parent awards managed by the National Institute of Environmental Health Sciences (NIEHS):
Srikanth S. Nadadur, Ph.D.
For parent awards managed by the National Institute of Drug Abuse (NIDA):
Kristopher Bough, Ph.D.